Table 1.

Patient characteristics at study entry (N = 250).^*

Age, years	51.0 ± 13.7
Women	195 (78%)
White, non-Hispanic	102 (418%)
Hispanic	73 (29%)
Black	56 (22%)
Asian	17 (7%)
Multi-ethnic	2 (1%)
Duration of RA, years	9.6 ± 10.0
Seropositive	188 (75%)
Erosive	141 (64%)†
Swollen joint count (0 – 66)	16 ± 9
Tender joint count (0 – 68)	25 ± 15
Physician global assessment (0 – 100)	48.2 ± 17.5
Erythrocyte sedimentation rate (mm/hr)	40 ± 27
Medications at entry
Methotrexate	87 (35%)
Hydroxychloroquine	64 (26%)
Sulfasalazine	24 (10%)
Leflunomide	16 (6%)
Prednisone	88 (35%)
Tumor necrosis factor-alpha inhibitors	28 (11%)
Other biologics	2 (1%)

^*Plus-minus values are mean ± standard deviation. All other values are number (percentage).

^†Of 221 patients with radiographs.